Initial commit
This commit is contained in:
318
skills/clinical-reports/assets/radiology_report_template.md
Normal file
318
skills/clinical-reports/assets/radiology_report_template.md
Normal file
@@ -0,0 +1,318 @@
|
||||
# Radiology Report Template
|
||||
|
||||
## Patient Information
|
||||
|
||||
**Patient Name:** [Last, First]
|
||||
**Medical Record Number:** [MRN]
|
||||
**Date of Birth:** [MM/DD/YYYY]
|
||||
**Age:** [years]
|
||||
**Sex:** [M/F]
|
||||
**Exam Date:** [MM/DD/YYYY]
|
||||
**Exam Time:** [HH:MM]
|
||||
**Accession Number:** [Number]
|
||||
|
||||
**Referring Physician:** [Name]
|
||||
**Ordering Service:** [Service/Department]
|
||||
|
||||
---
|
||||
|
||||
## Examination
|
||||
|
||||
**Exam Type:** [CT/MRI/X-Ray/Ultrasound/PET/Nuclear Medicine scan]
|
||||
**Body Part:** [Anatomical region - e.g., Chest, Abdomen and Pelvis, Brain]
|
||||
**Contrast:** [Yes - IV/Oral/Both | No]
|
||||
**Laterality:** [Right/Left/Bilateral if applicable]
|
||||
|
||||
---
|
||||
|
||||
## Clinical Indication
|
||||
|
||||
[Reason for examination, relevant clinical history, specific question to be answered]
|
||||
|
||||
Example: "Rule out pulmonary embolism in patient with acute dyspnea and chest pain. History of recent surgery."
|
||||
|
||||
---
|
||||
|
||||
## Comparison
|
||||
|
||||
**Prior Studies:**
|
||||
[Modality] of [body part] from [date]: [Available/Not available for comparison]
|
||||
|
||||
Example: "CT chest without contrast from 6 months prior (01/15/2023) available for comparison"
|
||||
|
||||
OR: "No prior imaging available for comparison"
|
||||
|
||||
---
|
||||
|
||||
## Technique
|
||||
|
||||
[Detailed description of imaging parameters and protocol]
|
||||
|
||||
**For CT:**
|
||||
```
|
||||
Multidetector CT of the [body region] was performed [without/with] intravenous
|
||||
contrast. [Volume] mL of [iodinated contrast agent name] was administered
|
||||
intravenously. Images were acquired in the [arterial/venous/delayed] phase(s).
|
||||
Multiplanar reconstructions were performed.
|
||||
|
||||
Technical quality: [Adequate / Limited by motion artifact / Limited by patient body habitus]
|
||||
Radiation dose (DLP): [mGy-cm]
|
||||
```
|
||||
|
||||
**For MRI:**
|
||||
```
|
||||
MRI of the [body region] was performed [without/with] intravenous contrast
|
||||
using the following sequences: [list sequences - T1, T2, FLAIR, DWI, etc.]
|
||||
[Volume] mL of [gadolinium-based contrast agent] was administered intravenously.
|
||||
Multiplanar imaging was obtained.
|
||||
|
||||
Technical quality: [Adequate / Limited by motion artifact]
|
||||
```
|
||||
|
||||
**For X-Ray:**
|
||||
```
|
||||
[Number] views of the [body part] were obtained: [AP/PA/Lateral/Oblique]
|
||||
Technical quality: [Adequate penetration and positioning / Limited by...]
|
||||
```
|
||||
|
||||
**For Ultrasound:**
|
||||
```
|
||||
Real-time ultrasound examination of the [body part] was performed using
|
||||
[linear/curved] array transducer.
|
||||
Technical quality: [Adequate / Limited by bowel gas / Limited by body habitus]
|
||||
```
|
||||
|
||||
---
|
||||
|
||||
## Findings
|
||||
|
||||
[Systematic, comprehensive description of findings organized by anatomical region or organ system]
|
||||
|
||||
### [Region/Organ 1]
|
||||
|
||||
[Detailed findings - size, density/intensity, enhancement pattern, abnormalities]
|
||||
|
||||
**Normal statement:** "[Organ] is normal in size, contour, and [attenuation/signal intensity]. No focal lesions."
|
||||
|
||||
**Abnormal statement:** "[Description of abnormality with measurements]"
|
||||
|
||||
Example:
|
||||
```
|
||||
Lungs:
|
||||
- Bilateral ground-glass opacities are present, predominant in the lower lobes.
|
||||
- Right lower lobe consolidation measuring 4.5 x 3.2 cm with air bronchograms.
|
||||
- No pleural effusion or pneumothorax.
|
||||
- Airways are patent bilaterally.
|
||||
```
|
||||
|
||||
### [Region/Organ 2]
|
||||
|
||||
[Findings]
|
||||
|
||||
### [Additional Regions as Applicable]
|
||||
|
||||
**For Chest CT:**
|
||||
- Lungs
|
||||
- Airways
|
||||
- Pleura
|
||||
- Mediastinum and Hila
|
||||
- Heart and Great Vessels
|
||||
- Chest Wall
|
||||
- Upper Abdomen (if included)
|
||||
- Bones
|
||||
|
||||
**For Abdomen/Pelvis CT:**
|
||||
- Liver
|
||||
- Gallbladder
|
||||
- Spleen
|
||||
- Pancreas
|
||||
- Kidneys and Adrenals
|
||||
- Gastrointestinal Tract
|
||||
- Peritoneum and Mesentery
|
||||
- Retroperitoneum
|
||||
- Bladder
|
||||
- Pelvic Organs
|
||||
- Vasculature
|
||||
- Lymph Nodes
|
||||
- Bones
|
||||
- Soft Tissues
|
||||
|
||||
**For Brain MRI:**
|
||||
- Brain Parenchyma
|
||||
- Ventricles and Cisterns
|
||||
- Extra-axial Spaces
|
||||
- Vascular Structures
|
||||
- Orbits (if included)
|
||||
- Skull Base and Calvarium
|
||||
|
||||
### Measurements (if applicable)
|
||||
|
||||
| Structure | Measurement | Normal Range |
|
||||
|-----------|-------------|--------------|
|
||||
| [Lesion/mass] | [Size in cm, 3 dimensions] | - |
|
||||
| [Organ] | [Size] | [Normal size] |
|
||||
|
||||
---
|
||||
|
||||
## Impression
|
||||
|
||||
[Concise summary of key findings with clinical interpretation]
|
||||
|
||||
**Format as numbered list in order of clinical importance:**
|
||||
|
||||
1. **[Most important finding]** - [Diagnosis or differential, clinical significance]
|
||||
- [Additional details, comparison to prior if applicable]
|
||||
- [Recommendation if any]
|
||||
|
||||
2. **[Second finding]** - [Interpretation]
|
||||
|
||||
3. **[Additional findings]**
|
||||
|
||||
**Alternative format for normal study:**
|
||||
```
|
||||
No acute intrathoracic abnormality.
|
||||
Specifically, no evidence of pulmonary embolism.
|
||||
```
|
||||
|
||||
**Recommendations (if applicable):**
|
||||
- [Further imaging, follow-up imaging interval, clinical correlation, biopsy, etc.]
|
||||
- [Timeframe for follow-up]
|
||||
|
||||
Example:
|
||||
```
|
||||
Recommend follow-up CT in 3 months to assess for interval change.
|
||||
Clinical correlation with laboratory values recommended.
|
||||
Consider PET/CT for further characterization if clinically indicated.
|
||||
```
|
||||
|
||||
---
|
||||
|
||||
## Communication of Critical Results
|
||||
|
||||
[If critical/urgent finding]
|
||||
|
||||
**Critical finding:** [Description]
|
||||
|
||||
**Communicated to:** [Name and role of person notified]
|
||||
**Date/Time:** [MM/DD/YYYY at HH:MM]
|
||||
**Method:** [Phone call / Page / In person]
|
||||
**Read back verified:** [Yes]
|
||||
|
||||
---
|
||||
|
||||
## Structured Reporting (if applicable)
|
||||
|
||||
### For Lung Nodules (Lung-RADS):
|
||||
**Category:** [Lung-RADS 0/1/2/3/4A/4B/4X]
|
||||
**Recommendation:** [Per Lung-RADS guidelines]
|
||||
|
||||
### For Breast Imaging (BI-RADS):
|
||||
**Category:** [BI-RADS 0/1/2/3/4/5/6]
|
||||
**Recommendation:** [Per BI-RADS guidelines]
|
||||
|
||||
### For Liver Lesions (LI-RADS):
|
||||
**Category:** [LI-RADS 1/2/3/4/5/M/TIV]
|
||||
**Features:** [Arterial phase hyperenhancement, washout, capsule, size, growth]
|
||||
|
||||
### For Prostate (PI-RADS):
|
||||
**Score:** [PI-RADS 1/2/3/4/5]
|
||||
**Location:** [Peripheral zone / Transition zone]
|
||||
|
||||
---
|
||||
|
||||
## Signature
|
||||
|
||||
**Interpreted by:**
|
||||
[Radiologist name, MD]
|
||||
[Board certification]
|
||||
[NPI number if required]
|
||||
|
||||
**Electronically signed:** [Date and time]
|
||||
|
||||
**Dictated:** [Date and time]
|
||||
**Transcribed:** [Date and time]
|
||||
**Signed:** [Date and time]
|
||||
|
||||
---
|
||||
|
||||
## Template Notes
|
||||
|
||||
### General Principles
|
||||
|
||||
**Be systematic:**
|
||||
- Use consistent order (head to toe, outside to inside)
|
||||
- Don't skip regions even if normal
|
||||
- Include pertinent negatives
|
||||
|
||||
**Be specific:**
|
||||
- Provide measurements (size in 3 dimensions for masses)
|
||||
- Describe location precisely
|
||||
- Use standardized terminology (RadLex)
|
||||
- Quantify when possible
|
||||
|
||||
**Be clear:**
|
||||
- Avoid ambiguous language
|
||||
- Make impression stand-alone
|
||||
- Answer the clinical question directly
|
||||
- State what IS present, not just what isn't
|
||||
|
||||
**Communication:**
|
||||
- Critical findings require immediate verbal notification
|
||||
- Document communication
|
||||
- Provide specific recommendations
|
||||
- Suggest next steps when appropriate
|
||||
|
||||
### Measurement Guidelines
|
||||
|
||||
**Lesions/Masses:**
|
||||
- Three dimensions: [length x width x height in cm]
|
||||
- Use consistent measurement method for follow-up
|
||||
|
||||
**Lymph Nodes:**
|
||||
- Short axis diameter in cm
|
||||
- Note morphology (round vs. oval)
|
||||
|
||||
**Organ Sizes:**
|
||||
- Use established normal ranges
|
||||
- Age and sex appropriate
|
||||
|
||||
### Comparison Statements
|
||||
|
||||
**Improved:**
|
||||
"Interval decrease in size of right upper lobe mass from 3.5 cm to 2.1 cm."
|
||||
|
||||
**Stable:**
|
||||
"Unchanged 8 mm left lower lobe nodule, stable for 2 years."
|
||||
|
||||
**Worsened:**
|
||||
"Interval increase in bilateral pleural effusions, now moderate on the right."
|
||||
|
||||
**New finding:**
|
||||
"New 1.5 cm right adrenal nodule, not present on prior CT."
|
||||
|
||||
### Differential Diagnosis Language
|
||||
|
||||
**Definite:** "Consistent with..."
|
||||
**Probable:** "Most likely represents..." or "Favors..."
|
||||
**Possible:** "Suggestive of..." or "Differential diagnosis includes..."
|
||||
**Uncertain:** "Cannot exclude..." or "Consider..."
|
||||
|
||||
### Recommendations
|
||||
|
||||
**Follow-up imaging:**
|
||||
- Specify modality, timing, and what to assess
|
||||
- "Recommend CT chest in 6-12 months to assess stability"
|
||||
|
||||
**Further characterization:**
|
||||
- "Consider MRI for further characterization"
|
||||
- "Ultrasound correlation recommended"
|
||||
|
||||
**Clinical correlation:**
|
||||
- "Clinical correlation with tumor markers recommended"
|
||||
- "Correlate with patient symptoms and physical examination"
|
||||
|
||||
**Biopsy/Intervention:**
|
||||
- "Consider biopsy for definitive diagnosis"
|
||||
- "Amenable to image-guided biopsy if clinically indicated"
|
||||
|
||||
|
||||
Reference in New Issue
Block a user